Sector: health
Conviction from: NASDAQ
Royalty Pharma acquires royalty interests in approved and development-stage prescription drugs, funding biopharmaceutical innovation in exchange for future royalty streams.
2 tracked filer(s) hold this · 0 opened, 1 added, 1 trimmed in 31-MAR-2026
Aggregate 13FScore 62 — mean of 2 scored holder(s) · buyers (new/add) avg 93. Higher = the smart money in this name has the better track record.
Beyond 13F — activists, insiders, politicians & research
| Filed | Form | Activist | % of class | Conviction | |
|---|
| 2026-02-20 | SCHEDULE 13D/A | Severgnini Achille G. | 5.7% | Med | filing |
2 disclosed trade(s) by 1 filer(s).